A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection
Status:
Not yet recruiting
Trial end date:
2023-03-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetic profiles of LP-001, an
amoxicillin and clavulanate formulation, for use in pediatric patients with a bacterial
infection.